Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank New EU rules for safe and high-quality medicines for animals become effective 28 January 2022NewsVeterinaryRegulatory and procedural guidanceMedicines Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched 25 January 2022NewsHumanClinical trials Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 24 January 2022NewsHumanCOVID-19Vaccines Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 January 2022NewsVeterinaryMaximum residue limitMedicines International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 January 2022NewsHumanCOVID-19 COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy 18 January 2022NewsHumanCOVID-19Vaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022 14 January 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines EMA welcomes EU Commissioner for Health and Food Safety 13 January 2022NewsCorporateCOVID-19 Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs 13 January 2022NewsHumanClinical trials Global regulators discuss path towards regulatory alignment on response to Omicron variant 13 January 2022NewsHumanCOVID-19Vaccines 1 … 47 48 49 50 51 Page 51 of 380 52 53 54 55 … 380
New EU rules for safe and high-quality medicines for animals become effective 28 January 2022NewsVeterinaryRegulatory and procedural guidanceMedicines
Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched 25 January 2022NewsHumanClinical trials
Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 24 January 2022NewsHumanCOVID-19Vaccines
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022 21 January 2022NewsVeterinaryMaximum residue limitMedicines
International regulators’ recommendations on COVID-19 vaccines and the Omicron variant 21 January 2022NewsHumanCOVID-19
COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy 18 January 2022NewsHumanCOVID-19Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022 14 January 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines
Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs 13 January 2022NewsHumanClinical trials
Global regulators discuss path towards regulatory alignment on response to Omicron variant 13 January 2022NewsHumanCOVID-19Vaccines